Edition:
United Kingdom

Histogenics Corp (HSGX.OQ)

HSGX.OQ on NASDAQ Stock Exchange Capital Market

2.03USD
20 Nov 2017
Change (% chg)

-- (--)
Prev Close
$2.03
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
12,640
52-wk High
$2.40
52-wk Low
$1.45

Select another date:

Thu, Nov 9 2017

BRIEF-Histogenics Corp announces Q3 loss per share $0.23

* Histogenics Corporation announces third quarter 2017 financial and operating results

BRIEF-Histogenics Corp promotes Stephen Kennedy to COO

* Histogenics Corporation promotes Stephen Kennedy to executive vice president & chief operating officer Source text for Eikon: Further company coverage:

BRIEF-Histogenics says Q2 loss per share $0.25

* Histogenics corporation announces second quarter 2017 financial and operating results

BRIEF-Histogenics on track for top-line one year superiority data, potential BLA filing in Q3 of 2018

* Histogenics completes enrollment for phase 3 clinical trial of neocart® to treat knee cartilage damage

BRIEF-Histogenics Corp appoints Donald Haut chief business officer

* Histogenics Corporation announces the appointment of Donald Haut, Ph.D. as chief business officer Source text for Eikon: Further company coverage:

Select another date: